共 50 条
- [45] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation Annals of Surgical Oncology, 2021, 28 : 5448 - 5449
- [47] Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Annals of Surgical Oncology, 2015, 22 : 1658 - 1663
- [50] Value-Based Health Care: The Fine Balance of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS ± HIPEC) Annals of Surgical Oncology, 2023, 30 : 7926 - 7928